How We Help Investors Despite some political and macroeconomic uncertainty, health care and life sciences sectors will continue to demonstrate high investment interest and activity, primarily due to reliable demand for patient care by an aging population with a significant and growing disease burden. Successful health care organizations will see the strategic imperative to find … Read more
How We Help Digital Health Companies Leavitt Partners provides expert advice, strategy support and tools to help address the complex issues facing digital health vendors. Our market assessments enable you to align your capabilities and offerings with the industry’s needs so that you enter the right markets at the right time. Our keen understanding of … Read more
How We Help Associations Leavitt Partners empowers associations to succeed in the evolving health care ecosystem through informing and advising them on the latest industry trends and developments. Our innovative tools, cutting-edge research, and subject matter expertise helps associations find solutions to complex challenges and support their strategic-planning process. Why We’re Different Leavitt Partners has … Read more
Informed strategies for success in healthcare markets. How We Help The United States health care system is undergoing a significant transformation, which will profoundly change the industry’s product and services transactions over the next decade. Leavitt Partners’ seasoned team of experts advises C-suite and other executives in making strategic decisions within the evolving heath care … Read more
PRIVACY POLICY Last Updated: January 14, 2021. Leavitt Partners, LLC and its subsidiaries and affiliates (collectively, “Leavitt Partners”, “us” or “we”) understand that your privacy is important to you. We are committed to respecting your privacy and protecting your personal data, which is any information that is capable of identifying you as an individual person. This … Read more
Leavitt Partners examined publicly available resources to determine the 340B Drug Pricing Program’s (340B) impact on drug prices charged by both covered entities and pharmaceutical manufacturers. To answer these questions, Leavitt Partners undertook a comprehensive literature review of publicly available governmental reports, peer-reviewed journal articles, white papers, news articles, and other publicly available sources to … Read more
Today, Health Management Associates (HMA) launched the Leavitt Center for Alliances, an HMA Initiative, which aims to elevate the national discourse on healthcare and help healthcare organizations solve their most complex challenges through consensus-based alliances. The Leavitt Center for Alliances (Leavitt Center) is home to expert conveners who have decades of experience in the private … Read more
In April 2022, we published a blog post exploring Q1 digital health funding within the US using a framework introduced by Leavitt Partners in a recently published whitepaper. Applying the same methods, we tracked funding across the digital health landscape In Q2. Q2 saw 144 deals in digital health for a total investment of $4.6 billion and an average deal … Read more
Partnership Calls on Policymakers to Implement Proposals in 2020 Landmark Report Washington, D.C. — In recognition of World Sickle Cell Day on June 19th, today more than a dozen organizations representing a diverse cross-section of patient advocates, health professional organizations, health insurers and biopharmaceutical companies announced the launch of the Sickle Cell Disease Partnership. The … Read more
COVID Patient Recovery Alliance’s Interim Report Outlines More Than Two Dozen Recommendations for Federal Policymakers To Help Promote Recovery and Restoration Washington D.C. — Today, the COVID Patient Recovery Alliance released an interim report, “Towards Recovery and Restoration: Policy Recommendations to Improve the Care of Individuals Living with Long-COVID.” The multi-sector alliance, convened by Governor … Read more
